46 results on '"Bianco, A.R."'
Search Results
2. The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy
3. Targeting c-erbB2 and Other Receptors of the C-ErbB Family: Rationale and Clinical Applications
4. Poly(ADP-ribose)polymerase (PARP-1) expression in malignant melanomas from photo exposed areas of the head and neck region
5. Epidermal growth factor receptor (EGFR) expression in cutaneous melanoma: A possible role as prognostic marker
6. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data
7. 1086 Cetuximab in a randomized phase II trial as a single agent or in combination with irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing, irinotecan-refractory metastatic colorectal cancer (CRC)
8. Recombinant IFN-α2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells
9. Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer
10. Second-Line Chemotherapy with a Hybrid-Alternating Regimen of Bolus 5FU Modulated by Methotrexate and Infusional 5FU Modulated by Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with 5FU
11. Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study
12. Oral administration of chimeric MBO antisense-protein kinase A inhibits growth, angiogenesis and growth factors production and cooperates with cytotoxic drugs in human cancer xenografts
13. Antiangiogenic and antitumor effect of VEGF antisense oligonucleotide in combination with anti-EGFR C225 monoclonal antibody in human colon cancer
14. A structured algorithm to assess the response to biological therapy in medullary thyroid carcinoma
15. P46 15 year update of the naples GUN trial of adjuvant breast cancer therapy: Evidence of interaction between c-erb-B2 expression and Tamoxifen efficacy
16. Mutations in the BRCA1 gene in it alian breast and ovarian cancer patients
17. Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study
18. 213 Phase II study of vinorelbine in elderly patients with stage IIIB-IV non small cell lung cancer
19. 212 Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study
20. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study
21. Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial
22. High-dose recombinant interleukin-2/verapamil combination in advanced cancer
23. Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?
24. First-line systemic therapy for metastatic breast cancer and management of pleural effusion
25. 45 ErbB2 overexpression affects tamoxifen efficacy in the adjuvant treatment of node negative operable breast cancer patients
26. Postmastectomy follow-up in patients with early breast cancer: Consensus or controversy?
27. α-Interferon Induces Depletion of Intracellular Iron Content and Up Regulation of Functional Transferrin Receptors on Human Epidermoid Cancer kb Cells
28. 5-Aza-2′-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells
29. Phase I study of carboplatin, epirubicin and VP-16 plus G-CSF in extensive small cell lung cancer (SCLC)
30. Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function
31. Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant surgery” for limited small cell lung cancer (SCLC)
32. High dose chemotherapy with epirubicin (E) and cyclophosphamide (C) plus hemopoietic colony stimulating factors in locally advanced (LABC) or metastatic (MBC) breast cancer. A phase I–II trial
33. Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy
34. Elevated serum levels of circulating intercellular adhesion molecule I in patients with liver disease treated with thymostimulin
35. Thynostimulin is effective treatment in hepatocellular carcinoma associated with liver cirrhosis
36. Cell Kinetics and Tumor-Associated Antigen Expression in Human Mammary Carcinomas
37. Second-Line Chemotherapy of Advanced Colorectal Cancer with Sequential High-Dose Methotrexate and 5-Fluorouracil
38. Impact of Preoperative CA 15-3 Levels in Operable Breast Cancer. Comparison with Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA)
39. Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant” surgery for limited small cell lung cancer (SCLC)
40. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization
41. Changing presentation in non-Hodgkin lymphoma
42. CA 15-3 in Human Breast Cancer.: Comparison with Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA)
43. Clinical Trial with 5-Fluorouracil and Leucovorin
44. The Source of Ascitic Fluid in Experimental Cirrhosis in the Rat
45. Tamoxifen in operable breast cancer
46. Studies of Some Immunological Properties of Thyroid Iodoproteins
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.